The EU’s increasing reliance on pharmaceutical production from non-EU countries, particularly India and China, has raised serious concerns, newly elected Czech MEP Ondřej Dostál (NI) said in an interview with Euractiv Czechia.
He points out that basic medicines are being sourced from outside Europe, making the EU vulnerable to supply chain disruptions. “In 2023, we witnessed certain supply…
